December 15, 2021
Press & Media
Denka Deepens the Strategic Partnership with PlexBio Through Acquiring Over One-third of Its Stake
2019.09.23
PlexBio Co.,Ltd., a Taipei, Taiwan-based clinical cancer diagnostics developer, and Denka Co., Ltd., Japanese chemical products firm has been in close collaboration since the signing of memorandum of understanding in 2015.
On September 19th, PlexBio announced that Denka acquired one-third of its stake. Denka thus becomes the biggest shareholder of PlexBio. This transaction is the largest investment between Taiwan and Japan in the biomedical industry. The two companies held a ceremony in celebration of the deepened strategic partnership and plans to expand product portfolio, enter various diagnostics markets, and further extend into new areas. Many distinguished guests attended the ceremony, including Mei-yueh Ho, the national policy to the president, Dr. Johnsee Lee, Chairman of Taiwan Biotech Industry Organization, Dr. Annie Liu, Director of the Office of Science and Technology of the Executive Yuan, Shu-Long Wang, Deputy Director of Consumer Goods and Chemical Industries Division of the Industrial Development Bureau, and other experts in the industry.
For complete announcement, please visit GENEONLINE
PlexBio Co.,Ltd., a Taipei, Taiwan-based clinical cancer diagnostics developer, and Denka Co., Ltd., Japanese chemical products firm has been in close collaboration since the signing of memorandum of understanding in 2015.
On September 19th, PlexBio announced that Denka acquired one-third of its stake. Denka thus becomes the biggest shareholder of PlexBio. This transaction is the largest investment between Taiwan and Japan in the biomedical industry. The two companies held a ceremony in celebration of the deepened strategic partnership and plans to expand product portfolio, enter various diagnostics markets, and further extend into new areas. Many distinguished guests attended the ceremony, including Mei-yueh Ho, the national policy to the president, Dr. Johnsee Lee, Chairman of Taiwan Biotech Industry Organization, Dr. Annie Liu, Director of the Office of Science and Technology of the Executive Yuan, Shu-Long Wang, Deputy Director of Consumer Goods and Chemical Industries Division of the Industrial Development Bureau, and other experts in the industry.
For complete announcement, please visit GENEONLINE
